RVP

Retractable Technologies Inc. Common Stock (RVP)

Stock · AMEX · Health Care

$0.58as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

RVP Announces Dividends for Series II & III Preferred Shares. Retractable Technologies reported that it will pay dividends to holders of its Series II and III Class B preferred stock. The announcement provides a cash return to preferred shareholders and may affect the stock’s yield expectations. The dividend declaration comes as the common shares trade near the middle of their 52‑week range.

Active signals

Resistance level
$0.679625
Industry
Medical/Dental Instruments

What RVP's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike52-1.1%42%
Bollinger Band BreakdownActive now24-2.8%46%
Bollinger Band Breakout16-2.1%38%
200-Day Moving Average TouchActive now10-2.9%40%
Any 20-session window (baseline)-1.7%40%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About RVP

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety ca…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
195

Fundamentals

1-day range
$0.576$0.5958
Market cap
$20.27M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
$-0.11
Dividend yield
—
Beta
1.30
Avg. volume
30.2K
52-week range
$0.5844$1.14

How Retractable Technologies Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$38.27MCost of Revenue$38.22M (100%)SG&A$19.59M (51%)R&D$675.6K (2%)Tax$291.3K (1%)RVP

Source: 10-K filed Mar 27, 2026 · via SEC EDGAR / Finnhub

Gross Profit$47.0K(0%)
Operating Income-$21.18M(-55%)

Retractable Technologies Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • RVP
    Retractable Technologies Inc. Common Stock
    $0.58
    ▼ 1.69%
    Market cap $20.27MP/E —
    $0.5844$1.14
  • PLRZ
    Polyrizon Ltd. Ordinary Shares
    $10
    ▼ 0.10%
    Market cap $21.51MP/E —
    $2.88$18.2
  • ADGM
    Adagio Medical Holdings Inc Common Stock
    $0.099
    ▼ 3.88%
    Market cap $16.26MP/E —
    $0.083$2.02
  • MDAIW
    Spectral AI Inc. Warrants
    $0.445
    ▲ 8.54%
    Market cap $15.91MP/E —
    $0.355$1.01
  • CTSO
    Cytosorbents Corporation Common Stock
    $4.11
    ▲ 34.31%
    Market cap $25.05MP/E —
    $2.96$18.8
  • OSRH
    OSR Health Inc. Common Stock
    $0.226
    ▲ 13.00%
    Market cap $15.32MP/E 12.44
    $0.075$0.9078
  • CNSY
    Cerenome Inc. Common Stock
    $1.7
    ▼ 9.57%
    Market cap $26.57MP/E —
    $1.49$4.16

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Institutional Ownership

March 31, 2026

Total shares held
2.41M
Total value held
$1.59M
Institutional holders
27
Top holders this quarter
  • Unknown581.7K
  • Unknown580.9K
  • Unknown404.0K
  • Unknown241.1K
  • Unknown149.4K
  • Unknown88.5K
  • Unknown59.8K
  • Unknown52.8K
  • Unknown50.6K
  • Unknown32.9K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.